Methyl-gbb

Methyl-gbb has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 19, 2026: “Drug improved survival in mice missing the enzyme statins target”.

Intervention

1 paper studies it4 findingsUpdated Oct 18, 2026

1 lab in 1 country

Animals1

What did studies of Methyl-gbb find?

Studies of Methyl-gbb measured 4 outcomes; the most studied are long-chain acylcarnitines (1 study), liver injury (1) and hypoglycemia (1).

Long-chain acylcarnitines

downin mice1

1 study

Methyl-gbb decreases long-chain acylcarnitines in mice.
“methyl-GBB markedly improved survival, prevented hypoglycaemia, reduced liver injury, preserved mitochondrial respiratory function, and normalized hepatic long-chain acylcarnitine profiles.”
Animalswhole-body Hmgcr-knockout miceliver
Drug improved survival in mice missing the enzyme statins target
Research SquareOct 18, 2026Preprint

Latest

1 paper in 12 months

Research SquareOct 19

Drug improved survival in mice missing the enzyme statins target

In a mouse experiment, the compound also prevented low blood sugar and reduced liver injury after loss of the enzyme blocked by statins.In a mouse experiment, the compound also prevented low blood sugar and reduced liver injury after loss of the enzyme blocked by statins.

Preprint: mouse studyMechanisms

Paper

Methyl-gbb

What did studies of Methyl-gbb find?

Latest

Drug improved survival in mice missing the enzyme statins target

Related